Table 4.
Statistical output grow-out phase (3): Nitric oxide production. Accumulated NO in the medium upon ex vivo LPS stimulation in the grow-out phase (3) was determined and used as a tool to investigate transgenerational effects of the maternal treatments (control, LPS, β-glucan).
Variable | Category | n | LSMeans | SEM | P-value |
---|---|---|---|---|---|
Maternal treatment | β-glucan | 141 | 2.45a | 0.17 | 0.0141 |
LPS | 136 | 2.73b | 0.17 | ||
Control | 131 | 2.02a | 0.17 | ||
Age | 14 | 124 | 3.36a | 0.18 | 0.0077 |
21 | 144 | 1.88b | 0.16 | ||
35 | 140 | 1.96b | 0.17 | ||
Ex vivo LPS stimulation | 0 | 104 | 0.86a | 0.19 | <0.0001 |
1 | 96 | 1.45ab | 0.20 | ||
10 | 104 | 1.72b | 0.19 | ||
10+0.1 IFNy | 104 | 5.57c | 0.19 | ||
R-square model | 0,52 |
Interaction age × Ex vivo LPS stimulation P < 0.01.
Different letters P < 0.05.